Ligand Pharmaceuticals (LGND) Inventory (2011 - 2026)

Ligand Pharmaceuticals (LGND) has 16 years of Inventory data on file, last reported at $13.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 9.22% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (down 9.22% YoY), and the FY2025 full-year result was $9.1 million, down 35.34% from the prior year.
• Inventory improved to $13.3 million in Q1 2026, from $9.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $26.9 million in Q2 2023 to a low of $9.1 million in Q4 2025.
• A 5-year average of $18.3 million and a median of $16.7 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory slumped 51.35% in 2022 and surged 80.3% in 2023, its largest moves.
• Tracing LGND's Inventory over 5 years: stood at $13.3 million in 2022, then surged by 80.3% to $24.0 million in 2023, then tumbled by 41.12% to $14.1 million in 2024, then slumped by 35.34% to $9.1 million in 2025, then jumped by 45.36% to $13.3 million in 2026.
• Business Quant data shows LGND's Inventory at $13.3 million in Q1 2026, $9.1 million in Q4 2025, and $11.9 million in Q3 2025.